BAY1213790

DRUG2 trials

Sponsors

Bayer

Conditions

Knee Arthroplasty, TotalRenal Dialysis

Phase 1

End-stage Renal Disease (ESRD) Pilot Study

CompletedNCT03787368

BayerRenal Dialysis

Start: 2019-01-31End: 2021-09-15Updated: 2022-03-16

Phase 2

FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty

CompletedNCT03276143

BayerKnee Arthroplasty, Total

Start: 2017-09-21End: 2019-01-02Updated: 2020-03-03

Related Papers

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty

JAMA2020-01-14241 citations